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The fourth joint meeting between scien-
tists from the National Institute of En-
vironmental Health Sciences in Research
Triangle Park, North Carolina, and the
Biological Safety Research Center (BSRC),
National Institute of Health Sciences
(NIHS), in Tokyo was held 2-3 March
1993, in Research Triangle Park. The pur-
pose ofthese meetings, held under the aus-
pices of the U.S.-Japan Agreement on
Cooperation in Research and Develop-
ment in Science and Technology, is to
exchange information on the toxicological
characterization of environmental chemi-
cals ofmutual interest (1-3). The emphasis
of the fourth joint meeting was on repro-
ductive.toxicology, updates on carcinogen-
esis studies, and the evaluation of several
alternative test systems for carcinogenic
and noncarcinogenic effects. New scientific
activities and directions of the BSRC/
NIHS, NIEHS, and the U.S. National
Toxicology Program (NTP) were also dis-
cussed.
Reproductive and Developmental
Toxicology
A number ofavailable strategies to evaluate
the potential reproductive and develop-
mental toxicity ofchemicals was discussed
and evaluated (4-6). Until recently,
emphasis in reproductive toxicity testing
has been on the male. However, in the
NTP database of nearly 100 chemicals
tested for reproductive toxicity, no chemi-
cal has demonstrated only male reproduc-
tive toxicity. All chemicals were either only
toxic to the female reproductive system or
to both the male and female (e.g., phtha-
late esters and glycol ethers). Yet, over the
last 10 years there have been numerous
reports examining the site and mechanism
of action of these chemicals in the male
with virtually no studies on the effects of
these chemicals in females.
An analysis of reproductive toxicity
studies over the past several years indicated
that there were very few endpoints mea-
sured in females compared to males in
reproductive toxicity studies. Also, there
was not a published, logical, integrated
approach to defining the site and mecha-
nism ofaction offemale reproductive toxi-
cants as had been developed for the male.
Furthermore, the use of ovarian histo-
pathology lagged severely behind that of
testicular histopathology. In the male, the
first reproductive toxicity test, because of
the numerous endpoints measured, can
often provide significant clues about the
identity of the target organ and lead
directly to an informed pathogenesis
study. For the female, however, often the
only information obtained in this type of'
study is a decrease in the number ofpups,
or perhaps a change in the estrous cycle.
Because the estrous cycle can be normal in
the presence ofsignificant adverse repro-
ductive effects in the female, this is con-
sidered an insensitive endpoint. Thus,
there are often few clues as to the target
site in the female. NTP scientists have
devised a logical approach to this problem
(Fig. 1). The approach includes the fol-
lowing measurements: crossover mating to
determine affected sex, implantation sites,
corpora lutea, live and dead pups, ovarian
weight, and ovarian histology. It could be
used as either the first assessment of
female toxicity or as a second-tier test,
after the initial reproductive toxicity
assessment. This approach should lead the
investigator to the target organ(s) of the
toxicant. The rationale for the design is as
follows:
Fewer live pups in treated females
(mated with untreated males) indicates a
female reproductive toxicant; altered
ligure 1. Scnemauc tor inmaiilly iaeniying me location ot reproductive toxicity in remales. uu, gestation-
day.
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estrous cyclicity and/or altered mating
behavior would substantiate this conclu-
sion. If there are fewer live pups but a
normal number ofimplantation sites, then
the effect occurs after implantation. This
would probably be the result of genetic
toxicity (dominant lethal mutation), devel-
opmental toxicity to the conceptus/fetus,
or lack of sustained and adequate corpus
lutea function, leading to hormonal insuf-
ficiency.
If the number of implantation sites is
decreased, then there is either a decrease in
the number of ovulated oocytes, or there
are effects on fertilization and/or implan-
tation. If the number of corpora lutea is
normal, this suggests alterations in the
oocyte, resulting in impaired fertil-
ization/implantation. If the number of
corpora lutea is decreased, superovulation
can theoretically be used to separate an
effect on the ovary from an effect on the
central hormonal control tissues [hypo-
thalamus and pituitary (H/P)]. In theory,
superovulation should be able to separate a
direct ovarian site ofaction from an indi-
rect ovarian effect, but this procedure has
not been assessed for this use (Fig. 2A).
In the event that the number ofcorpo-
ra lutea is normal (and implantation sites
are fewer), the superovulation test is not
needed because the ovary is shedding ade-
quate numbers of oocytes. Instead, that
group of animals may be used for a
pseudopregnancy test (Fig. 2B). Again,
this test has not been used for this applica-
tion, but it should suit the need, in theory.
A normal pseudopregnancy test implies
the successful development ofa functional
corpus luteum, which depends on leutiniz-
ing hormone and prolactin from the pitu-
itary. However, because pseudopregnancy
is shorter than pregnancy (12-14 days ver-
sus 19-21 days), and because the animals
are intentionally sacrificed after 9 days in
the pseudopregnancy test, problems that
developed later in gestation would not be
identified by this test.
If the pseudopregnancy test is abnor-
mal, it indicates a uterine, corpus luteal, or
H/P site ofaction. Thus, using this type of
approach should identify the site oftoxici-
ty as the ovary, H/P, fertilization, implan-
tation, or a combination ofthese. Ovarian
histology where one counts the number of
small, growing, and large follicles, the per-
centage ofeach ofthese that is atretic, and
the percentage ofdividing cells per follicle
can also be very useful in defining the site
ofaction ofa female reproductive toxicant
(Fig. 3). The assessment ofestrous cyclici-
ty and mating behavior can provide addi-
tional evidence supporting a proposed site
of action. Further experiments will then
determine the target cell within that tissue
(i.e., pathogenesis study) and explore pos-
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Figure 2. Tests thatwould be added to a fertility testto aid in the determination ofthe site(s) of action of a
female reproductive toxicant. The superovulation test distinguishes a direct ovarian action from that on
the hypothalamus and pituitary. This test is appropriate when one finds fewer live pups and fewer corpo-
ra lutea in treated females. The pseudopregnancy test is indicated when there are fewer live pups, with a
normal number of implantation sites. It distinguishes development toxicity from toxic effects on the
uterus, corpora lutea, and hypothalamus and pituitary.
Figure 3. Follicle classification scheme. Follicles are classified as small, medium (growing), or large
(antral) according tothis scheme based on their size and number of granulosa cells.
Figure 4. Subchronic toxicity screen including observations for reproductive and developmental toxicity.
Co, cohabit gd, gestation day; Bi, birth; Nec, necropsy. Shaded areas indicate days of chemical dosing.
Parameters of the screen were as follows: subchronic toxicity and male infertility: three doses plus con-
trol, n= 10/group; bodyweightstaken on days 3, 7, 11, 15, 19, 23, 28; modified functional observational bat-
tery; gross necropsy; histopathology on liver, kidney, testis; hematology on blood at termination; fertility
before and during chemical administration, epididymal sperm motility and total epididymal sperm count.
Females (a): subchronic toxicity and female fertility, three doses plus control, n = 10/group; body weights
taken on days 0, 4, 8, 12, 16, 20, 24, 28; percent pregnant; number of implants; number of corpora lutea.
Females (b): developmental toxicity, three doses plus control, n = 10 smear-positive females/group; con-
firm mating byvaginal smear or plug during cohabitation; dose females on gd 6-15; bodyweights taken on
days 0, 6, 10, 15, and postnatal days 1 and 4; number and weight of pups at postnatal days 1 and 4; uterine
implantation sites atnecropsy and postnatal day4.
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sible mechanisms of action. Details on set-
ting up an ovarian pathogenesis study have
recently been published (2).
Short-Term Reproductive/
Developmena ToxicityScreen
Several short-term tests for reproductive
and developmental toxicity to provide pre-
liminary screening data on the toxicity of
chemicals for which little or no data exist
were evaluated. These induded tests recom-
mended by the Organization for Economic
Cooperation and Development (OECD)
and short-term tests conducted by the
NTP.
Data were presented from work done at
NIEHS using a 21-day test for reproductive
and developmental toxicity that also incor-
porates general toxicity endpoints (Fig. 4).
Studies on ethylene glycol monomethyl
ether (EGME) (8) and indium trichloride
(9) indicate that a short-term test could be
useful in identifying the processes that are
most vulnerable to adverse chemical effects.
For example, with EGME, a known toxi-
cant for both the male and the developing
organism, effects were seen in both males
and females. With indium, the fetus was
primarily at risk: dead implants were found
in the absence of adverse effects on female
or male reproductive measures. The prelim-
inary study with indium was followed by a
conventional developmental toxicity test,
which confirmed fetal vulnerability and the
lack of malformations in soft or hard tis-
sues. This, in turn, was followed by in vitro
teratology studies, which demonstrated tox-
icity directly to the conceptus at doses as
low as 50 jiM (9). Long-term definitive
studies are planned with indium to verify
the degree and types of chronic toxicities
that were missed by the short test, if any.
This design points out the utility of using
two groups of females dosed differently:
one during gestation only and the other
dosed during ovulation and through the
first part of development (9). Data from
these groups together can be used to identi-
fy which part ofreproduction in females is
primarily affected: reproduction (ovulation,
fertilization, implantation)> or development
(fetal development after implantation).
This is a property unique to this design and
is not found in other short-term test
designs. This design is also now being used
by the NTP for rats, incorporating two
changes: 5 days (versus 3 for mice) ofmat-
ing are used to generate the pregnant
females for the gestational exposures, and
the length ofthe entire test is increased to
28 days. Increased exposure should increase
the probability of detecting toxicity.
NIEHS will continue to use this test for in-
house studies as needed and will incorpo-
rate components of other testing (e.g.,
OECD test) as appropriate.
OECD Reproductive/Developmental
Guidelines
The OECD proposed the guideline "Com-
bined Repeat Dose and Reproductive/
Developmental Toxicity Screening Test"
(Repro/Tox) for rapid screening ofhigh pro-
duction volume chemicals in 1990 (10).
NIHS/BSRC scientists have used this proto-
col, designed to detect general toxicological
effects simultaneously with reproduc-
tive/developmental effects (11). A number of
chemicals have been screened using this pro-
tocol (12), and an ad hoc expert meeting on
"Reproductive Toxicity Screening Methods"
was held at BSRC, NIHS, in October 1992
to evaluate the Repro/Tox protocol. The
Repro/Tox protocol is a very useful prelimi-
nary screening test, but it also has several
shortcomings. Studies on nitrobenzene were
conducted to examine whether disturbances
of fertility associated with testicular toxicity
can be detected by this screening test. In the
systemic toxicity component, histopatholog-
ical findings, such as atrophyofseminiferous
tubules in testis and reduction ofspermato-
zoa in epididymis, were detected. In the
reproductive/developmental component,
however, no effects on fertility were detect-
ed. Subsequent studies examined when the
testicular toxicity appeared and whether
changes in spermatogenic endpoints could
be detected. Testicular toxicity was detected
on day 7 oftreatment; effects on spermato-
genic endpoints on day 14; and influence on
fertility on day 21 of treatment. Since the
epididymal transit time ofthe sperm is more
than 10 days, a treatment period longer than
14 days is necessary to detect disturbances of
male fertility due to testicular effects. To
evaluate male fertility and sperm endpoints,
examination at 28 days after initial dosing is
recommended because this will make it pos-
sible to compare the results with those of28
repeated-dose toxicity tests.
Testicular Toxicology
The complex interactions ofthe various cells
of the testis make it especially difficult to
understand testicular toxicity. Histological
evaluations of testicular lesions induced by
adriamycin, cyclophosphamide, nitroben-
zene, ethane-1,2-dimethane sulfonate, ethyl-
ene glycol monomethyl ether, and cadmium
chloride strongly suggest that early changes,
rather than those occurring at late stages, are
ofparticular assistance in understanding the
mechanisms of action of these chemicals
(13).
Altemative Tests
Alternative models to evaluatedevelopmen-
tal toxicity. In response to the large num-
ber of chemicals that require testing for
developmental toxicity, in vitro systems
have been developed to serve as screening
tools. The time and cost-effectiveness of
such in vitro systems may allow them to be
used as screening systems to help establish
priorities for further assessment ofdevelop-
mental toxicity in vivo. One approach to
developmental toxicity hazard assessment
is the use ofwhole embryo screening tests.
Teratogenesis screening assays using whole
embryos have the potential to detect dis-
ruptions to the cellular mechanisms and
cell-cell interactions critical for the normal
process of development. Because of the
complexity of development, an intact
embryo may be better at predicting devel-
opmental toxicity as compared to individ-
ual cell types. Two such whole embryo sys-
tems involve the use of embryos of the
Drosophila melanogaster and the South
African clawed frog, Xenopus laevis.
Drosophila. Exposure of Drosophila
during developmental morphogenesis to
mammalian developmental toxicants has
indicated that this whole embryo system
has the potential for future use as a screen-
ing system. The assay includes malforma-
tion ofthe embryo as a distinct measure of
effect, separate from survival and general
growth endpoints. There are numerous
structural endpoints to examine in the
embryo potentially limiting its practical
usefulness as a screening device. In an
attempt to focus the system on a particular
endpoint or group of endpoints, previous
studies conducted in collaboration with the
National Institute of Occupational Safety
and Health identified an abbreviated ass-
say. It was shown that the predictive value
ofthe assay is maintained iflimited to the
evaluation ofthe distinct endpoint ofbent
humeral bristles. Based on these findings,
NIEHS we are is in the process of estab-
lishing a validation study for the Droso-
phila as a model system to screen chemicals
for their potential mammalian teratogenic
hazards (14).
FETAX. The frog embryo teratogene-
sis assay-xenopus (FETAX) is a 96-hr
whole embryo developmental toxicity test
that uses embryos of the South African
clawed frog, Xenopus laevis (15). Embryos
are exposed to the test chemical continu-
ously from the early blastula to the stage
46 free-swimming larvae. During this time
they undergo cleavage, gastrulation, and
organogenesis similar to mammals. These
processes involve all ofthe developmentally
important cellular events, including cell
division, interaction, migration, differenti-
ation, and death. In contrast to other
short-term or in vitroscreens, FETAX end-
points can potentially detect all four mani-
festations of mammalian developmental
toxicity: growth retardation, structural
malformations, death, and functional
deficits. Functional deficits are detected by
assessing locomotor activity and sensory
reflex responses and provide a limited eval-
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uation of the neural network. Terato-
genicity has been detected for a variety of
chemicals and complex mixtures, including
selenium (16), aromatic amines (17), and
complex shale oil mixtures (18).
To increase the predictive accuracy of
the FETAX system to detect mammalian
developmental toxicants that require meta-
bolic activation, an exogenous metabolic
activation system was developed (19,20).
This system uses the addition ofAroclor
1254- or Isoniazid-induced rat liver micro-
somes, which convert proteratogens such
as cyclophosphamide to an active terato-
genic form. A multilaboratory validation
study is currently being conducted by the
NTP to further determine the repeatability
and reliability of the FETAX system as a
developmental toxicity screening test. A
total of20 coded chemicals that have been
tested by the NTP in rodents will be used
in the validation study including both
strong and weak teratogens, nonteratogens,
and teratogens that require metabolic acti-
vation. Studies are being conducted by
other laboratories to elucidate the mecha-
nisms by which chemicals cause develop-
mental abnormalities in the FETAX sys-
tem.
Preliminary validation tests have dem-
onstrated the potential of each of these
embryo systems to identify hazard and
have stimulated additional studies to estab-
lish data to meet the criteria for in vitro
teratogenesis assayvalidation.
Postimplantation Embryo Culture.
The usefulness of the in vitro test using
postimplantation rat embryo culture to
evaluate developmental toxicity oflow lev-
els of environmental chemicals was dis-
cussed. 2-Chlorodibenzofuran, a contami-
nant in chlorinated tap water, and seleni-
um were found to be teratogenic using this
in vitro test (21,22). The use ofthis in vitro
culture of postimplantation embryos has
several advantages: 1) it requires only small
amounts oftest chemicals; 2) embryotoxic-
ity similar to that observed in vivo has been
demonstrated for several chemicals; and 3)
maternal toxicity is eliminated.
The whole embryo culture system has
many benefits in determining the direct
effects of an agent, such as precise embry-
onic staging at the time of exposure, and
ability to control the concentration of test
agent. However, the lack of maternal
metabolizing and excretion systems may
limit the direct extrapolatation between
effects produced in vitro and those ob-
served in vivo. Ethanol is an example ofan
agent that is rapidly metabolized and elim-
inated in vivo. In fact, after a teratogenic
dose of ethanol in vivo, the parent com-
pound only has a 2- to 6-hr half-life in the
maternal serum (23). However, when the
effects of ethanol have been evaluated in
vitro, most studies have used 24- to 48-hr
exposure periods. NTP scientists evaluated
the developmental toxicity of ethanol in
vitro using concentrations and exposure
periods that mimicked those that were ter-
atogenic in vivo. The effects of ethanol in
vitrowere characterized by craniofacial dys-
morphogenesis and growth retardation.
The incidence and severity of these effects
were highly dependent on the concentra-
tion and length of exposure. For example,
to induce neural tube closure defects, an 8-
to 12-hr exposure period to a high ethanol
concentration (600-800 mg/dl) was re-
quired (24). These studies further indicate
that dispositional information must be
considered when assessing the toxicity of
an agent in vitro.
The culture system has also been used
to study embryonic metabolism and nutri-
tion at the early neurulation stage. It is cur-
rently accepted that the predominate route
ofenergy production is from the glycolytic
metabolism ofglucose (25-27). Using spe-
cific metabolic inhibitiors, recent work
indicates that mitochondrial metabolism
appears to be important for normal devel-
opment and energy production. Con-
tinuing work will focus on understanding
the apparent lack of glucose utilization by
the Krebs cycle and the identification of
the substrates used for the Krebs cycle and
oxidative phosphorylation.
Carcinogenesis Studies
Update on NTPefforts. The NTP has rec-
ognized the importance of incorporating
additional mechanistic studies into chronic
toxicity/carcinogenicity assays and has ini-
tiated a number of collaborative ties with
other researchers to incorporate mechanis-
tic studies. For example, in collaboration
with a nonprofit research institute, eight
investigators were provided rats from the
NTP ozone study for their research. These
studies provide functional, structural, and
biochemical studies on the NTP ozone-
exposed animals. These mechanistic studies
will be reported in conjunction with the
basic NTP studies and will provide crucial
and timely data on ozone, as the United
States is currently reevaluating the stan-
dards on ozone. Dibutyl phthalate, an
important U.S. Clean Air Act chemical
(and hazardous waste chemical), is also
being studied in collaboration with
NIEHS intramural scientists to provide the
necessary mechanistic information. Di-
butyl phthalate is of special interest to
NTP and NIEHS scientists because it is
found in the blood of most people, causes
proliferation of peroxisomes in animals,
appears to act through a receptor, and can
provide useful mechanistic data that may
be applicable to other chemicals. Carbon
disulfide, another important U.S. Clean
Air Act chemical, is being studied in col-
laboration with investigators from the
Health Effects Research Laboratory, En-
vironmental Protection Agency, and with
the extramural NIEHS program to provide
the mechanistic information on the neuro-
toxicity ofthis chemical.
Update on NIHS/BRCefforts. Urinary
bladder carcinogenesis from melamine has
been reported to occur in rodents with
urolithiasis. Studies on the relationship
between urolithiasis and urinary bladder
carcinogenesis revealed that sodium chlo-
ride supplementation in the diet inhibited
not only calculus formation but also the
hyperplastic lesions and tumors induced by
melamine. These results suggest that the
tumors and hyperplastic lesions ofthe uri-
nary bladder were secondary to calculus
formation and not directly attributable to
the biological effects of melamine.
Similarly, the chemical bisacodyl induces
both calculi and epithelial proliferative
lesions in the urinary bladder ofmale rats,
and studies indicate that bisacodyl-induced
proliferative lesions were not caused direct-
ly by bisacodyl but were secondary to cal-
culus formation (29).
Studies to compare the in vitrocytotox-
icity and in vivo tissue responses induced
by natural rubber latex materials were eval-
uated. The in vivo implantation test
showed that among 13 histological para-
meters, thickness ofthe inflammatory layer
was the most useful index to evaluate tissue
responses quantitatively. A comparison of
two in vitro cytoxicity assays (colony assay
using V79 cells and the agar diffusion assay
with L929 cells) showed that the colony
assay provided a more reliable prediction
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of the tissue response than the agar diffu-
sion assay (30).
Several problems with the evaluation of
rodent carcinogenicity in endocrine organs
were presented. Potassium pyrophosphate,
a food additive, induced tubular necrosis
in kidneys oftreated female F344 rats (2.5
and 5% in diet) and high-dose male rats.
Chronic nephropathy and diffuse hyper-
plasia ofthe parathyroid gland and fibrous
osteodystrophy in bone were also observed
in high-dose females. These changes sug-
gest the onset of persistent hypercalcemia,
which may cause adrenal medullary prolif-
erative lesions (31). The increased inci-
dence of pheochromocytomas and of
adrenal medullary proliferative lesions in
treated females may be attributable to the
persistent hypercalcemia and should be
considered secondary to severe, prolonged
renal toxicity.
Analysis ofcell proliferation in sponta-
neous proliferative lesions in the adrenal
medulla of F344 rats used in 2-year car-
cinogenicity studies was performed by
determining labeling indices for proliferat-
ing cell nuclear antigen (PCNA), mitotic
indices, and numbers of silver-stained
nucleolar organizer regions (AgNORs)
(32). The lesions were classified into
hyperplasia, well-differentiated medullary
tumor (WMT), atypical medullary tumor
showing cellular pleomorphism and atypia
(AMT), and malignant medullary tumor
with invasion or metastasis (MMT) cate-
gories. The PCNA labeling index and the
number ofAgNORs in proliferative lesions
ofthe rat adrenal medulla exhibited a step-
wise increase from normal medullary cells
through WMT, AMT, and MMT. These
data indicate that theAMT cannot be defi-
nitely classified, despite its marked cellular
atypia, as one ofthe malignant or metastat-
ic tumors.
Thyroid follicular proliferative lesions
were induced in male F344 rats treated
with high and low doses of thiourea (TU)
and sulfadimethoxine (SDM) for 20
weeks. However, rats treated with TU or
SDM did not reveal any consistent changes
in plasma T3, T4 and thyroid-stimulating
hormone (TSH)'levels, except for high-
dose TU group, which showed decreased
plasma T3 and T4 and increased TSH.
Prolonged stimulation ofthe thyroid-pitu-
itary feedback mechanism, which results in
elevation ofplasma levels ofTSH, leads to
thyroid tumors (33). However, consistent
changes in thyroid hormones and TSH
levels were not found in rats treated with
TU and SDM for 20 weeks. Therefore, the
present studies may suggest that prolonged
stimulation of the thyroid gland by excess
of TSH is not always needed for the pro-
motion and progression ofthyroid prolifer-
ative lesions.
Brain tumors induced by transplacental
application of ethylnitrosourea (ENU) in
F344 rats mainly consisted immunohisto-
chemically of two distinct types of vi-
mentin-expressing cellular nests termed
"perivascular small cellular nest" (PSCN)
and "large cellular nest" (LCN). PSCNs
contained cells expressing glial fibrillary
acidic protein (GFAP), neuron-specific
enolase (NSE), and low-affinity nerve
growth factor receptor (LNGFR). LCNs
contained cells showing a neuronal pheno-
type that expressed low- and middle-mole-
cular-mass neurofilament proteins as well
as NSE and LNGFR. Topographically,
bidirectional cell transitions from PSCNs
to astrocytes and LCNs was discerned. The
present study suggests that ENU-induced
"gliomas" (34) originate from pluripotent
germinal neuroepithelium and that PSCN
plays a role as cell source both for astrocyt-
ic and neuronal lineages.
The NIHS/BSRC is conducting car-
cinogenicity tests on the following chemi-
cals: Trp-P-2, potassium pyrophosphate,
ferric chloride, melamine, tannic acid,
trimethyl cyclohexane, cyanoguanidine,
stevioside, cyclodextrin, n-paraffin, potassi-
um iodide, histidine, jasamycin. Chemicals
tested for chronic or subchronic toxicity
are: rare earth metals, N-N-dimethyl-
ethanolamine, a-methylbenzylphenol,
tributoxyethyl phosphate, p-methylben-
zenesulfonmethyldiiodide.
Using Fish to Evaluate Chemical
Carcinogens
In the last 15 years, the use of small fish
species in carcinogenicity testing has
gained momentum. The small fish model
offers many advantages as a bioassay test
system: 1) Significant savings in cost and
time over rodent studies because large
numbers ofanimals can be maintained in a
limited area and certain species of the
teleost family are hardy and easily bred
under standardized laboratory conditions.
2) Inbred strains with low spontaneous
tumor rates have been developed that will
help reduce the variability in tests; these
strains have effectively demonstrated the
carcinogenic effects of certain chemicals
under experimental conditions in a shorter
time period than necessary for rodent stud-
ies (35-34. 3) When used as a screening
system, aquatic studies can provide toxicol-
ogy information that could lead to fewer
and better designed studies in rodents.
Toxicokinetic studies can be designed for
aquatic animals (38). Determining the
level of test chemical or its metabolites in
biological samples can be used to deter-
mine bioavailability, to select doses, and to
correlate toxic effects with systemic avail-
ability. 4) Physiological features of aquatic
organisms (i.e., total exposure in an aque-
ous environment and the aquatic gill sys-
tem have similarities to the more costly
rodent inhalation studies) provide unique
opportunities for certain mechanistic stud-
ies. There are also natural advantages for
evaluating chemical mixtures and chemi-
cals found in water (39).
In December 1991 a "Workshop of
Carcinogenesis Testing with Fish" was
held at the National Institute of En-
vironmental Health Sciences to evaluate
the utility ofthe small fish model. NIEHS
is currently planning to conduct long-term
(16-month exposure) studies in two species
of small fish which will provide an excel-
lent opportunity to combine the advanced
fish technology with the established, exact-
ing study conduct and reporting require-
ments of an NTP 2-year rodent carcino-
genicity study. Three compounds will be
tested, each of which has been previously
indicated to be a carcinogen in the NTP
rodent model. This will help evaluate the
utility of the small fish model in hazard
characterization and how it can be related
to rodent studies.
Conclusion
The U.S. and Japanese participants agreed
that the data presented during the meeting
on reproductive toxicology, carcinogenesis
studies, and alternative test systems was
very timely and beneficial. The meeting
provided a forum for the U.S. NTP and
theJapanese NIHS to design future collab-
orative studies on environmental chemicals
of mutual interest, thus avoiding duplica-
tion ofeffort.
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